NitroMist NovaDel Pharma - Treatment for Angina Pectoris

NitroMist is an oral spray formulation of nitroglycerin indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.

Related Articles:

FDA Accepts Submission for NitroMist as Complete Response - May 26, 2006

NovaDel Pharma Receives Approvable Letter from the FDA for NitroMist - nitroglycerin lingual aerosol - June 2, 2005

NovaDel NDA for Nitroglycerin Lingual Spray is Accepted for Review by FDA - September 29, 2004

NovaDel Pharma files for US FDA approval of Nitroglycerin Lingual Spray, its first product - June 21, 2004

Latest FDA Drug Approvals...

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals